Antimicrobial peptides (AMPs) are short amino acidic sequences with less than 100 residues. They are the components of the innate immune system not only in humans but also in plants, insects, and primitive multicellular organisms. Their role is to counteract the microorganisms, which could be potentially pathogenic for the host. AMPs active against viruses, bacteria, fungi, and parasites have been described. Among the antiparasitic AMPs reported so far, some peptides affect Plasmodium development in different phases of the biological cycle, from asexual blood stages to sexual stages in the mosquito, where AMPs can block ookinetes viability or oocyst formation. AMPs with antimalarial activity derive from different organisms, especially insects, as well as amphibians. In malaria research, AMPs have been mainly proposed for the engineering of mosquitoes or parasites to reduce or interrupt the malaria parasite transmission. In this chapter, the different classes of antimalarial AMPs (defensins, cecropins, dermaseptins) or single peptides (scorpine, melittin, gambicin) are described.
Introduction
Antimicrobial peptides (AMPs) are components of innate immunity, the arm of the immune system in charge for the first defense against pathogens, not only in humans but also in plants, insects, and primitive multicellular organisms. AMPs are short amino acidic sequences with less than 100 residues with a secondary structure which can be used for their classification (Table 7 .1) (Giuliani et al. 2007 ).
They have a broad spectrum of activity against many microorganisms like Gram positive and negative bacteria, fungi, and protozoa, but also viruses. Furthermore, antitumor activity for AMPs has also been reported (Hoskin and Ramamoorthy 2008) .
AMPs have a rapid action (minutes to hours) but they are usually active in the micromolar range, at higher doses compared to other antibiotics.
Although the mechanisms of action of the majority of AMPs are not precisely defined, interference with membranes is recognized as the main activity. Figure 7 .1 schematizes the most known hypotheses on the mode of action of AMPs on the membranes of microorganisms. The nonspecific activity on membranes gives to AMPs the advantage that they should be less prone to induce resistance in the target organisms, being their mechanism of action not connected to a specific target. However, this resistance-proof of AMPs has to be demonstrated. On the other side, S. D'Alessandro (*) Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy e-mail: sarah.dalessandro@unimi.it V. Tullio Dipartimento di Oncologia, Università degli Studi di Torino, Torino, Italy G. Giribaldi Dipartimento di Scienze della Sanità Pubblica e Pediatriche, Università degli Studi di Torino, Torino, Italy a disadvantage of the activity on cell membranes could be potential mammalian cell toxicity. This is true for some AMPs (e.g., gramicidin A, see paragraph 2.8), but not for others (e.g., some dermaseptin derivatives, see Sect. 2.6), which are specific for the membranes of microorganisms. In these cases, the difference in activity could be due to differences in lipid composition of membranes (cholesterol proportion or fluidity).
Beyond the activity at the membrane level, other intracellular targets such as protein or DNA synthesis have also been identified for some AMPs (Brogden 2005) .
Due to their ability to penetrate cell membranes, AMPs have been proposed as vector for drug delivery (Splith and Neundorf 2011) .
AMPs are difficult to be classified due to their huge diversity. The classifications can be based on different features, including amino acidic sequence (e.g., presence of cysteine residues, prevalence of particular amino acids, and presence of conserved sequences), membrane activity, secondary structure, and toxicity (Table 7 .1). 
Antimicrobial Peptides in Malaria
Some AMPs of different origin are known to affect Plasmodium development in different phases of the biological cycle, from asexual blood stages (cecropin, melittin, magainin, dermaseptin S4) to sexual stages in the mosquito, where AMPs can block ookinetes viability (VIDA 1-3, scorpine) or oocyst formation (VIDA 1-3) (Bell 2011) . A recent work by Carter and colleagues investigated the effect of 33 AMPs on Plasmodium early sporogonic stages, verifying that they did not alter mosquitoes' fitness (Carter et al. 2013 ). Table 7 .2 summarizes the antiplasmodial activity of some AMPs.
The secondary structure of AMPs has been used to predict the activity on different Plasmodium stages. For instance, Arrighi and colleagues designed new AMPs starting from natural or synthetic antimicrobial polypeptides and observed that peptides with no particular secondary structures (containing mainly random coils and turns) were more active on the sporogonic stages of P. berghei and P. yoelii (Arrighi et al. 2002) .
Some antimalarial AMPs are hemolytic or toxic, whereas others specifically act on the membrane of infected red blood cells (RBCs) or directly on the membrane of the parasite and not on the membrane of uninfected RBCs. An example is given by dermaseptin S4, which is hemolytic and disrupts uninfected RBCs too. Development of more selective substitutes was necessary to decrease toxicity (Krugliak et al. 2000) . 
Antimalarial AMPs Source
Antimalarial AMPs can be produced by mammalian hosts and mosquito vectors, as well as other organisms, which are not related to malaria (Table 7. 3). AMPs are part of the immune defense of mosquitoes, and Plasmodium infection can modulate AMPs expression in the Anopheles mosquito ( Fig. 7. 2). Vizioli and (Vizioli et al. 2000 ). Another example is described by Herrera-Ortiz and colleagues, who demonstrated that the mRNAs of attacin, cecropin, and gambacin were overexpressed in the midgut and abdominal tissue of mosquitoes fed with P. berghei-infected mouse blood (HerreraOrtiz et al. 2011 ).
The majority of AMPs with antimalarial activity described by Carter and colleagues were derived from bee/wasp venoms (Carter et al. 2013) .
Other examples of organisms producing AMPs with antimalarial activity are the scorpio Pandinus imperator, from which scorpine was isolated; the Cecropia moth which produces Cecropins; and Xenopus laevis, from which Magainin was extracted.
Defensins
Defensins represent the most important human AMPs as they are present at high concentrations (up to millimolar ranges) in epithelial and phagocytic cells. Their structure is characterized by a fold rich in beta-sheets and disulfide bonds between pairs of cysteines. The direct role of human defensins in malaria is not clear. Overexpression of a rat defensin (NP-1) was observed in a rat malaria model. Such enhancement was associated to protection of the young rats from lethal infection. That work supported a role for defensin in the immunity reaction to malaria infection (Pierrot et al. 2007 ). However, no direct studies on human defensins and malaria have been published.
Defensins are also part of the immune system of mosquitoes: their structure differs from that of human defensins, since it contains an alpha-helix linked to a betasheet. The role of mosquito defensins in malaria infection is better described compared to human defensins (Dixit et al. 2008; Hoffmann 1997; Meredith et al. 2008) . Defensin expression, constitutive in mosquitoes midgut, is further induced by malaria infection (Richman et al. 1997; Vizioli et al. 2001b ). The injection of defensin in Aedes egypti inhibited the development of Plasmodium sexual stages, resulting in oocyst abnormal development (Shahabuddin et al. 1998) . The treatment of sporozoites with defensin decreased their viability.
However, a reverse genetic approach demonstrated that defensin is not necessary in A. gambiae (Blandin et al. 2002) . The gene of defensin was disrupted in A. gambiae by treatment with dsRNA. This knockdown approach decreased the mosquito resistance to bacterial infections but did not alter the ookinete/oocyst formation or oocyst number after infection with P. berghei. 
Scorpine
Scorpion venom is a rich source of peptides with different pharmacological activities. Interestingly, AMPs have been found in scorpion venom, and they may have different functions: the defense of scorpions from bacterial infection, the immobilization of their prey, or the synergistic activity with other venom toxins (Simard and Watt 1990) .
In particular, scorpine (amino acid sequence in Table 7 .4) is extracted from the venom of the scorpion Pandinus imperator. It was tested for the first time against Plasmodium due to its similarity, in the peptide sequence, to cecropins and defensins, already known for their antimalarial activity (Conde et al. 2000) .
Scorpine decreased in a dose-dependent manner the fecundation of P. berghei parasites (measured as number of rosettes) and the formation of ookinetes (Conde et al. 2000) . The inhibition of ookinetes formation in P. berghei was confirmed by Carballar-Lejarazù and colleagues, who also demonstrated the inhibition of asexual P. falciparum parasites in vitro (Carballar-Lejarazú et al. 2008) . The authors used recombinant scorpine produced by transfected A. gambiae cells (cell line Sua 5.1). The plasmid for transfection was designed in order to make scorpine expressed under the control of the A. gambiae serpin promoter. They also created transgenic Drosophila, demonstrating that the expression of scorpine is not toxic to the insect. Such a paper was proposed as a proof of concept for the development of recombinant mosquitoes, an approach already proposed by Possani et al. (2002) , as described below.
Cecropins, Melittin, and Cecropin-Melittin Hybrids
Cecropins are a group of insect-derived inducible antibiotic peptides from the giant silk moth Hyalophora cecropia. Cecropins A and B AMPs were fully characterized by Boman and colleagues, a work published by Nature and reproduced on 
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The Journal of Immunology representing a pillar article in immunology (Steiner et al. 2009 ) (see Fig. 7 .3 for cecropin structure). Cecropin B affected oocyst development in the A. gambiae -P. cynomolgi model (Gwadz et al. 1989) . Some derivatives, namely Shiva-1, Shiva-2, and Shiva-3, were designed starting from the cecropin amino acidic sequence (Rodriguez et al. 1995; Yoshida et al. 2001) . They inhibited the sexual stages of P. berghei as well as ookinete and sporozoite development in the mosquito model.
The structural conformation of melittin was described by Wade and colleagues as percentages of alpha-helixes, beta-sheet, and random coils (Wade et al. 1990) .
Few years later the possibility of improving the antibacterial and antimalarial activities by creating hybrids between cecropin and melittin was explored (Boman et al. 1989 ). The properties of cecropins along with melittin and megainin to form ion channels in biologic membranes were studied in the 1990s (Wade et al. 1990 ). The amino acidic sequence of cecropin A, melittin, and two hybrids is reported in Table 7 .4.
Magainin
Magainins were originally isolated from the skin of the African clawed frog Xenopus laevis (Zasloff 1987) . Magainin (amino acidic sequence in Table 7 .4) is active against different bacteria, such as Escherichia coli, Streptococcus pyogenes, and Pseudomonas aeruginosa, by forming pores in the membranes. Magainin affects the viability of others microorganisms, including Saccharomyces cerevisiae and Plasmodium spp (Gwadz et al. 1989) . Some derivatives were developed. However, none of them were approved by FDA after clinical trials since they did not display increased activity compared to existing antibacterials or because they implicated toxicity issues. The structural conformation as percentages of alphahelixes, beta-sheet, and random coils (see Fig. 7 .4) was described by Wade and colleagues (Wade et al. 1990) . 
Dermaseptins
Dermaseptins are a family of AMPs isolated from frogs of the Phyllomedusa genus with cytolytic activity against bacteria, protozoa, yeast, and filamentous fungi. Ghosh and colleagues compared hemolytic dermaseptin S4 (amino acidic sequence in Table 7 .4) with nonhemolytic dermaseptin S3 for their physical properties (aggregation in solution and dissociation in membranes, binding to and interaction with RBCs) and for the effect on P. falciparum growth in vitro (Ghosh et al. 1997) . Several derivatives were prepared starting from dermaseptin S4, with many showing a selective activity on the membrane of infected RBCs compared to the activity on the membranes of normal RBCs (Krugliak et al. 2000) . The effects of dermaseptin S4 and its derivatives on malaria parasites were further investigated with respect to stage specificity Efron et al. 2002) .
Gambicin
Gambicin (amino acidic sequence in Table 7 .4) was first isolated from the conditioned medium of the Anopheles gambiae cell lines 4a-3A and 4a-3B (Vizioli et al. 2001a) . The activity on different microorganism was tested and gambicin inhibited the growth of Micrococcus luteus, E. coli SBS363, and Neurospora crassa. Gambicin was also effective against P. berghei ookinetes. Moreover, as other AMPs, the expression of gambicin was enhanced by Plasmodium infection. In 2006, Dong and colleagues studied the immune response of Anopheles gambiae to the human P. falciparum or the murine P. berghei malaria parasites (ookinete stage) by DNA microarray analyses and RNAi gene silencing assays (Dong et al. 2006) . The two species induced the expression of different genes and the authors confirmed the different ability to modulate the mosquito immune response to malaria. 
Other Antimalarial AMPs
A possible classification of antimalarial AMPs is described by Bell (2011) . Cationic, amphipathic "host-defense" peptides such as defensins and cecropins were treated in this chapter. Other membrane-active peptide antibiotics, such as gramicidin, have high activity on Plasmodium in the nanomolar range but they are also toxic for mammalian cells. Cyclosporine A, representative of the hydrophobic peptides class, was studied in all the Plasmodium stages and is active especially in the murine models. Thiopeptides, such as thiostrepton, have antimalarial activity but quite high IC 50 . Some other naturally occurring or synthetic peptides have been shown to have antimalarial activity. The antiprotozoal activity of AMPs from amphibian origin was reviewed by Rivas and colleagues (Rivas et al. 2009 ).
Potential Application of AMPs in Malaria Research and Control
AMPs have been investigated as potential drugs against different Plasmodium stages and in particular against the erythrocytic phase, which is largely associated with the symptoms of the disease (Khadjavi et al. 2010) . Recently, the interest of the research community and health authorities has moved toward elimination/eradication programs. To reach this ambitious goal, blocking transmission becomes an important step and AMPs could be reevaluated for their activities against the sexual stages, occurring throughout the mosquito vector. The most described application for AMPs in malaria is mosquito and parasite engineering to reduce or interrupt malaria parasite transmission (Carter and Hurd 2010) . Possani and colleagues proposed to insert the genetic code for bioactive peptides extracted from scorpion venom (scorpine mainly) into Anopheles mosquitoes to make them resistant to malaria infection (Possani et al. 2002) . The authors started from evidence from the literature that P. gallinaceum ookinetes injected in Drosophila melanogaster were able to develop into sporozoites identical to those obtained in mosquitoes and, as expected, able to infect chickens. They designed a strategy involving Drosophila as an investigation tool to study AMPs toxicity against insects and Plasmodium development within the insect. However, the authors did not go beyond the design of this strategy and did not show results of the transgenic work, only referring to preliminary, encouraging results.
A big issue with these transgenesis approaches is represented by the ethical concern in releasing transgenic insects in the environment.
A different approach is to engineer those microorganisms living in mosquitos' midgut. In this case, the aim is to make the vector resistant to malaria parasites. Metarhizium anisopliae fungi were transfected with salivary gland and midgut peptide 1 (SM1), scorpine, or an antibody that agglutinates sporozoites. Mosquitoes were infected with this microorganism, leading to a reduction of sporozoites production by more than 50 %, with the best result, 98 % reduction, obtained with scorpine (Fang et al. 2011) . 223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270 271  272  273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310 
